JODI BULT: Open Payments
NPI 1669447900 · DYER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 39 payments from 18 companies in 2025. Trend: 2023 $409 · 2024 $537 · 2025 $760
Food & beverage: $760
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $112 |
| Novo Nordisk Inc | 6 | $102 |
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| Organon LLC | 2 | $49 |
| Lilly USA, LLC | 2 | $49 |
| PFIZER INC. | 3 | $46 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Amgen Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $32 |
Products named: REXULTI, NEXPLANON, MOUNJARO, VRAYLAR, OTEZLA, Cologuard Collection Kit, QULIPTA, UBRELVY.
Industry payments across IN — which companies pay providers there.
